The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

$ 13.50

4.5
(405)
In stock
Description

We launched Calibrate with the mission to change the way the world treats weight. In our first year, we have proven that Calibrate works. Our combination of doctor-prescribed, FDA-approved GLP-1…

The Time for Calibrate is Now. Calibrate raises $100 Million Series B…, by Isabelle Kenyon

The Time for Calibrate is Now

Rebecca Torrence on LinkedIn: Inside the struggles at Calibrate, a new kind of weight-loss startup…

Have You Heard The News?

Isabelle Kenyon – Medium

Inside Calibrate, The Telehealth Newcomer Using Doctors And Coaches To Disrupt The $70 Billion Weight Loss Industry

With the GLP-1 market expected to surpass $100B in revenue, all eyes are on telehealth

CEO of Ozempic prescription startup Calibrate steps down as investors eye 'rapid downsizing' of consumer business

Calibrate taps new CEO, unveils partnership with OptumRx

Ep439: Isabelle Kenyon Founder & CEO, Calibrate

Isabelle Kenyon, founder of Calibrate, wants to improve metabolic health to drive sustainable weight loss - Levels

Samantha Lynch on LinkedIn: Female-Founded Telehealth Startup Calibrate Announces $22.5 Million Series…

Have You Heard The News?

Sara Reistad-Long on LinkedIn: Today Calibrate is accelerating our transformation into an…